Product image of Mometasonfuroaat Glenmark (Mometasone Furoate) supplied by GNH India

Mometasonfuroaat Glenmark

Active Ingredient:
Mometasone Furoate
Origin:
EU

Mometasonfuroaat Glenmark (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasonfuroaat Glenmark, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions affecting adults and children, including atopic dermatitis, psoriasis and seborrheic dermatitis.

GNH India supplies Mometasonfuroaat Glenmark as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on timely delivery, comprehensive documentation and regulatory compliance for global distribution.

Manufacturer / TM Owner

Glenmark Arzneimittel Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mometasone furoate is a topical corticosteroid that modulates inflammatory pathways in skin disorders.

  • Atopic dermatitis: reduces erythema, itching and scaling, helping restore skin barrier function.
  • Psoriasis: diminishes plaque thickness and inflammation, improving lesion appearance.
  • Seborrheic dermatitis: alleviates redness and flaking on scalp and facial areas.

How It Works

  • Mometasone furoate binds to intracellular glucocorticoid receptors, forming a complex that translocates to the nucleus and interacts with glucocorticoid response elements. This modulates transcription of anti‑inflammatory genes while suppressing pro‑inflammatory cytokines, chemokines and adhesion molecules, leading to reduced cellular infiltration, edema and immune activation in the skin.

Side Effects

Topical application of mometasone furoate may be associated with local and systemic adverse reactions.

Common Side Effects

  • Skin irritation: mild burning or stinging at the application site.
  • Dryness: localized skin dryness or scaling.
  • Pruritus: transient itching.
  • Erythema: mild redness.
  • Folliculitis: small pustules around hair follicles.

Serious or Rare Side Effects

  • Skin atrophy: thinning of the epidermis with prolonged use.
  • Telangiectasia: visible small blood vessels.
  • Hypopigmentation: loss of skin colour.
  • Secondary infection: bacterial, fungal or viral infection of treated area.
  • Systemic effects: adrenal suppression with extensive application.

Precautions & Warnings

When using mometasone furoate, consider the following precautions to minimise risk.

  • Application area: limit to affected skin and avoid large surface areas.
  • Duration: use for the shortest period necessary; discontinue if no improvement within 2‑4 weeks.
  • Age restrictions: avoid use in infants under 2 years unless prescribed.
  • Concomitant therapy: do not combine with other potent topical steroids without medical guidance.
  • Occlusion: avoid covering treated skin with airtight dressings unless directed.
  • Store at below 25°C: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Mometasone furoate may interact with other agents; review the following categories.

Major Interactions (Avoid)

  • Systemic corticosteroids: increased risk of systemic side effects.
  • CYP3A4 inhibitors (e.g., ketoconazole): may raise local drug levels.
  • Antifungal agents applied to the same area: potential additive irritation.
  • Live vaccines: topical steroids may reduce local immune response.

Moderate Interactions (Monitor Closely)

  • Antihistamines: may mask early signs of irritation.
  • Topical NSAIDs: monitor for enhanced skin thinning.
  • Phototherapy: increased risk of skin atrophy when combined.

Frequently Asked Questions

Mometasonfuroaat Glenmark contains mometasone furoate, a topical corticosteroid indicated for inflammatory skin disorders such as atopic dermatitis, psoriasis and seborrheic dermatitis. It helps reduce redness, itching and scaling associated with these conditions.

Mometasone furoate binds to glucocorticoid receptors inside skin cells, altering gene transcription. This up‑regulates anti‑inflammatory proteins and down‑regulates pro‑inflammatory cytokines, chemokines and adhesion molecules, thereby decreasing cellular infiltration, edema and immune activation.

The dosage and frequency are determined by the prescribing healthcare professional based on the severity of the skin condition, the area to be treated and patient age. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

Safety in pregnancy and lactation has not been definitively established. The prescriber will weigh potential benefits against risks and may advise alternative therapy if there are concerns. Women who are pregnant, planning pregnancy or breastfeeding should discuss use with their doctor.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Mometasone furoate is a high‑potency class II topical corticosteroid, offering strong anti‑inflammatory effects with a relatively low risk of systemic absorption when used as directed. Compared with lower‑potency agents, it may achieve faster symptom control, but clinicians balance potency against potential skin‑thinning risks.

Store the product at temperatures below 25 °C in its original packaging. Keep it away from moisture, direct sunlight and heat sources. Do not freeze. Proper storage helps maintain product stability and efficacy.

Apply a thin layer to the affected skin area once or twice daily, as directed by the prescriber. Gently rub in until the medication is fully absorbed. Wash hands before and after application, unless the hands are being treated.

Serious risks include skin atrophy, telangiectasia, hypopigmentation and secondary infections. Extensive or prolonged use can lead to systemic effects such as adrenal suppression. Patients should report any unusual skin changes, persistent irritation or signs of infection promptly.

Individuals with known hypersensitivity to mometasone furoate or any formulation excipients should avoid use. It is also contraindicated on infected skin without appropriate antimicrobial therapy, on large body surface areas for prolonged periods, and in infants under two years unless specifically prescribed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Mometasone Furoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT